1-3 of 3
I. James
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

EZH1-PRC2 Identifies a Potential Reservoir for Disease Relapse in Quiescent Cancer Cells Refractory to EZH2 Enzymatic Inhibition

Evan Healy, Rachel McCole, Craig Monger, James Nolan, Eric Conway, Gerard Brien, Cheng Wang, Hannah K Neikes, Frances Potjewyd, Michiel Vermeulen, Aoibhinn Mooney, Richard Flavin, Elisabeth Vandenberghe, Lindsey I James, Adrian P Bracken
Journal: Blood
Blood (2022) 140 (Supplement 1): 3049–3050.
https://doi.org/10.1182/blood-2022-168762
Published: 2022
Journal Articles

Pharmacokinetics and Pharmacodynamics of CNTO 528, a Novel Erythropoietin Receptor Agonist in Normal and Anemic Rats.

Peter Bugelski, PhD, T. Nesspor, T. Spinka-Doms, D. Makropoulos, E. Eirikis, J. Fisher, A. Volk, K. Shamberger, I. James, P. Fisher, C. Pool, H. Jang, B. Miller, C. Huang, G. Heavner, D. Knight, J. Ghrayeb, B. Scallon
Journal: Blood
Blood (2005) 106 (11): 4261.
https://doi.org/10.1182/blood.V106.11.4261.4261
Published: 2005
Journal Articles

Mild preconditioning and low-level engraftment confer methotrexate resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity

Rohaizah I. James, Christopher A. Warlick, Miechaleen D. Diers, Roland Gunther, R. Scott McIvor
Journal: Blood
Blood (2000) 96 (4): 1334–1341.
https://doi.org/10.1182/blood.V96.4.1334
Published: 2000